Trial Details

COMPLETED
Basic Information
Clinical ID c3965
Identifier NCT01258205
Trial Title Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: AMG 139
Participant Information
Sponsor AstraZeneca
City Berlin
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2011-02-28
Primary Completion Date 2015-02-18
Completion Date 2015-02-18